EN

CN EN

Aurisco gets Auxiton Approval.

Release time：2023-06-26

Aurisco Pharmaceutical’s Oral Dydrogesterone Tablets Get Marketing

Authorization Approval in China Under The Brand Name AUXITON^®.

See attachment for details:

Aurisco gets Auxiton Approval_final

Next：Aurisco will Exhibit at CPHI South East Asia Last：Sirnaomics visited Yangzhou Aurisco

About Us: Who we are; Milestone; Corporate culture; Corporate social responsibility (CSR); Press releases

Sustainability & Compliance: Sustainability and Compliance; Quality system; EHS; Goals and Plans for Carbon Neutrality; Supply Security

R&D,Science Innovation: Innovation and IP Security; R&D Center; Our Science; Our Pipeline; Tech Platforms

Product & Service: API; FDF; CRO&CDMO

Manufacturing Sites: Facilities

Investor Relations: Secretary's Mailbox; CompanyProfile; EquityStructure; CompanyAnnouncement

Contact Us: Job openings; Career Opportunity; Contact us

Follow Aoruite WeChat official account

版权所有奥锐特药业股份有限公司 Copyright © 2020 AURISCO.All Rights Reserved 浙ICP备17058154号-1 Legal Notice

Enterprise mailbox